Pap smear
"Cervical Cancer Screening"[MeSH Terms]
CDC cervical cancer screening Pap test recommendations 2025
https://www.cdc.gov/pcd/issues/2025/25_0139.htm

Can you make short gynaecology and obstruction notes for my exam last moment revise
Overall every single topic
Mbbs
Which section should I make first?

Make notes of every topic of gyne and obs
Which block should I turn into concise exam notes first?

Ok
"Abnormal Uterine Bleeding" AND management
ACOG abnormal uterine bleeding amenorrhea dysmenorrhea guidance
| Ovarian cycle | Endometrial cycle | Main hormone/event |
|---|---|---|
| Follicular phase | Proliferative phase | FSH stimulates follicles; estrogen proliferates endometrium |
| Ovulation | Late proliferative | LH surge causes ovulation, about 14 days before next period |
| Luteal phase | Secretory phase | Corpus luteum produces progesterone |
| Luteolysis | Menstruation | Fall in estrogen and progesterone causes shedding |
Ok
endometriosis AND management
CDC pelvic inflammatory disease STI treatment guidelines 2026 bacterial vaginosis trichomoniasis candidiasis
| Condition | Discharge | pH | Key finding | Treatment principle |
|---|---|---|---|---|
| Candidiasis | Thick, white, curdy | Normal, <4.5 | Intense pruritus, erythema; pseudohyphae on KOH | Azole antifungal |
| Bacterial vaginosis | Thin, homogeneous grey-white, fishy odour | >4.5 | Clue cells, positive whiff test | Metronidazole |
| Trichomoniasis | Frothy yellow-green, offensive | >4.5 | Strawberry cervix, motile trichomonads | Metronidazole, treat partner |
| Gonorrhoea/chlamydia cervicitis | Mucopurulent endocervical discharge | Variable | Friable cervix, contact bleeding | NAAT and organism-directed treatment |
| Feature | Fibroid | Adenomyosis |
|---|---|---|
| Uterus | Irregular, firm | Uniformly enlarged, boggy |
| Lesion | Well-defined mass | Diffuse myometrial infiltration |
| Common feature | Pressure symptoms, HMB | HMB with severe dysmenorrhoea |
| Definitive surgery | Myomectomy/hysterectomy | Hysterectomy |
Ok
"Ectopic Pregnancy" AND management
WHO abortion care guideline contraception family planning ectopic pregnancy management guidance
| Factor | Common causes |
|---|---|
| Male | Semen abnormality, varicocele, endocrine disease, infection, erectile/ejaculatory dysfunction |
| Ovulatory | PCOS, hyperprolactinaemia, thyroid disease, premature ovarian insufficiency |
| Tubal/peritoneal | PID, genital TB, previous pelvic surgery, endometriosis |
| Uterine | Fibroid, polyp, adhesions, congenital anomaly |
| Cervical | Rare as an isolated cause |
| Unexplained | Normal standard evaluation but no identified cause |
| Category | Examples | Main point |
|---|---|---|
| Natural | Fertility awareness, lactational amenorrhoea, withdrawal | Higher failure rate in typical use |
| Barrier | Male/female condom, diaphragm | Condoms reduce STI transmission |
| Hormonal | COC, progestin-only pill, injectables, implants | Highly effective with correct use |
| IUCD | Copper IUCD, LNG-IUS | Long-acting reversible contraception |
| Permanent | Vasectomy, tubectomy | For completed family |
| Type | Features | Cervix | Management principle |
|---|---|---|---|
| Threatened | Bleeding, mild pain, viable pregnancy possible | Closed | Observe, USG, supportive care |
| Inevitable | Bleeding/pain, products may be felt | Open | Evacuation or expectant/medical care as appropriate |
| Incomplete | Some products expelled | Open | Stabilise, uterine evacuation/medical management |
| Complete | All products expelled | Closed | Confirm completion |
| Missed | Nonviable pregnancy retained | Closed | Expectant, medical, or surgical evacuation |
| Septic | Fever, foul discharge, uterine tenderness | Variable | Resuscitation + broad antibiotics + evacuation after stabilisation |
| Situation | Management |
|---|---|
| Unstable/ruptured/suspected major haemoperitoneum | Immediate resuscitation and surgery |
| Stable, selected unruptured ectopic | Expectant, medical methotrexate, or surgery depending on clinical criteria |
| Surgical treatment | Laparoscopic salpingectomy or salpingostomy in selected cases |
| Type | Typical feature | Mechanism |
|---|---|---|
| Stress urinary incontinence | Leakage on cough, laugh, exercise | Urethral hypermobility or sphincter weakness |
| Urgency urinary incontinence | Sudden urge followed by leakage | Detrusor overactivity |
| Mixed | Both stress and urgency features | Both mechanisms |
| Overflow | Continuous dribbling, poor stream, high residual urine | Retention/obstruction or weak detrusor |
| Functional | Cannot reach toilet due to disability/cognition | Non-urological cause |
Ok
"Cervical Cancer Screening"[MeSH Terms]
WHO cervical cancer screening and treatment guidelines HPV test 2024 2025 cervical cancer facts
| Stage | Key point |
|---|---|
| I | Confined to cervix |
| II | Beyond cervix, but not pelvic wall/lower third vagina |
| III | Lower third vagina, pelvic wall, hydronephrosis, or regional nodes |
| IV | Bladder/rectal mucosa or distant metastasis |
| Cancer | Most important risk factor | Typical presentation | Diagnosis | Main treatment principle |
|---|---|---|---|---|
| Cervix | Persistent high-risk HPV | Postcoital bleeding | Cervical biopsy | Surgery early, chemoradiation advanced |
| Endometrium | Unopposed estrogen/obesity | Postmenopausal bleeding | Endometrial biopsy | TH + BSO with staging |
| Ovary | Age, BRCA, family history | Bloating, mass, ascites | Histopathology | Debulking surgery + chemotherapy |
| Vulva | HPV or lichen sclerosus | Persistent pruritus/ulcer | Vulval biopsy | Wide local excision + node assessment |
Ok
preeclampsia AND management
WHO antenatal care pre-eclampsia gestational diabetes pregnancy guidance
| Maternal | Fetal/neonatal |
|---|---|
| Fatigue, reduced work capacity | Fetal growth restriction |
| Heart failure in severe anaemia | Preterm birth |
| Increased risk from PPH/sepsis | Low birth weight |
| Poor puerperal recovery | Perinatal morbidity/mortality |
| Infection | Important fetal/maternal issue | Core exam point |
|---|---|---|
| Rubella | Congenital rubella syndrome: cataract, cardiac defect, deafness | Vaccinate before pregnancy, not during pregnancy |
| Toxoplasmosis | Chorioretinitis, hydrocephalus, intracranial calcification | Avoid undercooked meat/cat litter exposure |
| Syphilis | Stillbirth, congenital syphilis | Screen early; penicillin prevents congenital infection |
| HIV | Vertical transmission | ART, viral-load-based delivery plan, infant prophylaxis |
| Hepatitis B | Perinatal transmission | Neonatal immunoprophylaxis |
| Malaria | Maternal anaemia, miscarriage, stillbirth | Prompt diagnosis/treatment in endemic region |
| UTI/pyelonephritis | Preterm labour, maternal sepsis | Screen/treat bacteriuria as per protocol |
Ok
labor induction AND cesarean delivery
WHO intrapartum care labour induction operative vaginal birth caesarean section recommendations
| Feature | True labour | False labour |
|---|---|---|
| Contractions | Regular, increasing frequency/intensity | Irregular, do not progressively increase |
| Pain | Starts in back, radiates to abdomen | Usually lower abdomen |
| Cervix | Progressive effacement and dilatation | No progressive change |
| Sedation/rest | Does not stop labour | Often settles symptoms |
| Stage | Definition | Key events |
|---|---|---|
| First stage | Onset of true labour to full cervical dilatation, 10 cm | Effacement and dilatation |
| Second stage | Full dilatation to delivery of baby | Descent, rotation, expulsion |
| Third stage | Delivery of baby to delivery of placenta and membranes | Placental separation and delivery |
| Fourth stage | First 1-2 hours after placenta | Watch for PPH and maternal stability |
| Diameter | Measurement | Clinical importance |
|---|---|---|
| Suboccipitobregmatic | 9.5 cm | Engaging diameter in well-flexed vertex |
| Occipitofrontal | 11.5 cm | Deflexed vertex |
| Mentovertical | 13.5 cm | Brow presentation, usually cannot deliver vaginally |
| Submentobregmatic | 9.5 cm | Face presentation with mentum anterior |
| Biparietal diameter | 9.5 cm | Largest transverse diameter of head |
| Feature | Forceps | Ventouse |
|---|---|---|
| Traction | More controlled/stronger | Less traction force |
| Maternal trauma | Higher | Lower |
| Fetal scalp trauma | Less scalp injury | More scalp bruising/cephalohaematoma |
| Use in face presentation | May be used in selected cases | Contraindicated |
| Preterm fetus | Often preferred over vacuum in selected situations | Generally avoided in very preterm baby |
| Intraoperative/early | Late |
|---|---|
| Haemorrhage, infection, bladder/bowel injury | Adhesions |
| Anaesthetic complications, thromboembolism | Scar ectopic pregnancy |
| Wound complications | Placenta previa/accreta spectrum in later pregnancy |
| Delayed recovery | Uterine rupture risk in future labour |
Ok
"Obstructed Labor" AND management
WHO obstructed labour uterine rupture breech cord prolapse clinical guidance
| Maternal | Fetal |
|---|---|
| Uterine rupture | Hypoxia/asphyxia |
| PPH, shock, sepsis | Birth trauma |
| Bladder injury | Stillbirth/neonatal death |
| Vesicovaginal or rectovaginal fistula | |
| Acute kidney injury | |
| Maternal death |
| Type | Description |
|---|---|
| Frank breech | Hips flexed, knees extended |
| Complete breech | Hips and knees flexed |
| Footling breech | One or both hips and knees extended, foot presents first |
Ok
"Postpartum Hemorrhage" AND management
WHO postpartum haemorrhage prevention treatment antepartum haemorrhage puerperal sepsis newborn resuscitation guidelines
| Feature | Placenta previa | Placental abruption |
|---|---|---|
| Bleeding | Bright red, visible | Dark blood, may be concealed |
| Pain | Painless | Painful |
| Uterus | Soft, non-tender | Tender, tense/woody |
| Fetal status | Often initially reassuring | Frequently compromised |
| Presentation | Malpresentation/high head common | Usually cephalic unless another issue |
| PV examination | Digital PV contraindicated until excluded | May be done only after previa excluded |
| Cause | Examples |
|---|---|
| Tone | Uterine atony, most common cause |
| Trauma | Cervical/vaginal/perineal tears, uterine rupture, inversion |
| Tissue | Retained placenta, retained products, placenta accreta spectrum |
| Thrombin | DIC, thrombocytopenia, coagulation disorders |
| Type | Duration | Appearance |
|---|---|---|
| Lochia rubra | First 3-4 days | Red, blood-stained |
| Lochia serosa | About day 4-10 | Pink/brown |
| Lochia alba | Up to 4-6 weeks | Yellowish-white |
| Condition | Onset/features | Management principle |
|---|---|---|
| Postpartum blues | First week, tearfulness, mild mood lability; resolves within 2 weeks | Reassurance, support |
| Postpartum depression | Persistent low mood, loss of interest, impaired function | Mental-health assessment, psychotherapy ± medication |
| Postpartum psychosis | Delusions, hallucinations, severe agitation/confusion; emergency | Urgent psychiatric and obstetric care, protect mother and infant |
Can you please help me out about the OB-D case? Uh, a woman from marriage since two year came to my OB-D. Uh, she wants to conceive, and she has past history of, uh, PCOS, and, uh, she had a treatment for that before the marriage. After the marriage, she say about-- she says, according to her, her periods was normal, uh, at, uh, first two to three months. After that, she had again, uh, issues in her cycles, uh, and now she wants to conceive. Now, kindly can you, uh... Tell me, uh, how to take history? Uh, what, what should I, workups I do, uh, test and all that, and what treatment should I suggest that patient?
"Polycystic Ovary Syndrome" AND infertility
2023 international evidence based guideline PCOS infertility assessment letrozole first line ovulation induction
A woman married for 2 years presents with inability to conceive despite regular unprotected intercourse. She has a past history of PCOS and currently has irregular menstrual cycles, suggesting ovulatory dysfunction. I would take a detailed infertility history, examine both partners where possible, exclude pregnancy and other endocrine causes of irregular cycles, and assess the three basic fertility factors: ovulation, semen parameters, and tubal patency.
| Factor | Test |
|---|---|
| Male factor | Semen analysis |
| Ovulation | Menstrual history, progesterone if needed, follicular monitoring |
| Uterus/ovaries | Transvaginal USG |
| Tubes | HSG, or laparoscopy with chromopertubation when indicated |
In this woman, I would diagnose primary infertility with suspected anovulatory infertility due to PCOS. I will first confirm that she is not pregnant, take a complete menstrual, PCOS, sexual, medical, and past-treatment history, and evaluate the husband simultaneously. Examination will include BMI, BP, signs of hyperandrogenism and insulin resistance, thyroid and pelvic examination. Investigations include TSH, prolactin, androgen testing when indicated, glucose assessment, pelvic USG, semen analysis, assessment of ovulation, and tubal patency testing as indicated. After lifestyle and preconception counselling, I would use supervised letrozole ovulation induction if anovulation from PCOS is confirmed and male/tubal factors have been excluded.
If I receive a patient married since two to three year or maybe five to six years, and now she wants to conceive, uh, what should be the history asked and the, the treatment, the follow-ups, and, uh, workup? Well done. Can you please make a list and...
"Infertility" AND evaluation
ASRM fertility evaluation infertile women committee opinion semen analysis tubal patency ovulation 2025
| Fertility factor | Investigation |
|---|---|
| Pregnancy | Urine pregnancy test or serum beta-hCG before fertility treatment |
| Male factor | Semen analysis |
| Ovulation | Menstrual history, ovulation tracking, mid-luteal progesterone when indicated |
| Uterus/ovaries | Transvaginal pelvic ultrasound |
| Tubal patency | HSG or HyCoSy; laparoscopy only when indicated |
In a couple with infertility, I will assess both partners simultaneously. I will confirm the duration of regular unprotected intercourse, take a detailed menstrual, obstetric, sexual, medical, gynaecological, lifestyle, and male-partner history, and perform general and pelvic examination. Initial tests are pregnancy testing, semen analysis, assessment of ovulation, pelvic ultrasound, and assessment of tubal patency where indicated. Treatment is cause-specific, with preconception counselling and lifestyle optimisation for all couples. In anovulatory PCOS without male or tubal factor, supervised letrozole is first-line ovulation induction. Follow-up includes monitoring ovulation, pregnancy testing, metabolic risk control, and timely escalation to IUI, IVF, or specialist referral.